Khaled Ibrahim
Impact in
-
- Nanoparticle-Based Drug Delivery
Papers in
- Oncology 5
- Cancer Treatment and Pharmacology 3
- PARP inhibition in cancer therapy 1
-
- Renal cell carcinoma treatment 1
- Co-authors
- Jie Shen (1 shared paper)Lingxiao Xie (1 shared paper)Ali Shamseddine (5 shared papers)Hassan Hatoum (3 shared papers)Nadine Haddad (4 shared papers)Fadi Farhat (3 shared papers)Nizar Bitar (4 shared papers)Joseph Kattan (4 shared papers)
- Journals
- Journal of Clinical Oncology (2 papers)Clinical Breast Cancer (1 paper)Future Oncology (1 paper)Pharmaceutics (1 paper)European Journal of Cancer Supplements (1 paper)
- Partner nations
- LebanonUnited StatesSaudi Arabia
In The Last Decade
Khaled Ibrahim
8 papers receiving 117 citations
Peers
Comparison fields: 5 of 43
- Biomaterials 43
- Molecular Medicine 12
- Pharmaceutical Science 11
- Ophthalmology 8
- Oncology 24
Countries citing papers authored by Khaled Ibrahim
This map shows the geographic impact of Khaled Ibrahim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khaled Ibrahim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khaled Ibrahim more than expected).
Fields of papers citing papers by Khaled Ibrahim
This network shows the impact of papers produced by Khaled Ibrahim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khaled Ibrahim. The network helps show where Khaled Ibrahim may publish in the future.
Co-authors
The 25 scholars most cited alongside Khaled Ibrahim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 41 | |
| 2 | 2021 | 35 | |
| 3 | 2010 | 13 | |
| 4 | 2010 | 13 | |
| 5 | 2009 | 7 | |
| 6 | 2018 | 6 | |
| 7 | 2023 | 2 | |
| 8 | 2011 | 1 |
About Khaled Ibrahim
Khaled Ibrahim is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Organic Chemistry, Molecular Biology and Geriatrics and Gerontology, having authored 8 papers that have together received 118 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (3 papers), PARP inhibition in cancer therapy (1 paper), Click Chemistry and Applications (1 paper), Renal cell carcinoma treatment (1 paper), Cancer Genomics and Diagnostics (1 paper), Corneal Surgery and Treatments (1 paper), Telomeres, Telomerase, and Senescence (1 paper) and Ocular Surface and Contact Lens (1 paper). The work is most often cited by research in Biomaterials (43 citations), Molecular Medicine (12 citations), Pharmaceutical Science (11 citations), Ophthalmology (8 citations) and Oncology (24 citations). Khaled Ibrahim has collaborated with scholars based in Lebanon, United States and Saudi Arabia. Frequent co-authors include Jie Shen, Lingxiao Xie, Ali Shamseddine, Hassan Hatoum, Nadine Haddad, Fadi Farhat, Nizar Bitar, Joseph Kattan, Sally Temraz and Moosa Patel. Their work appears in journals such as Journal of Clinical Oncology, Clinical Breast Cancer, Future Oncology, Pharmaceutics and European Journal of Cancer Supplements.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.